VACEK, Lukáš, Dominika POLAŠTÍK KLEKNEROVÁ, Břetislav LIPOVÝ, Jakub HOLOUBEK, Dominika MATYSKOVÁ, E. CERNA, J. BRTNIKOVA, E. JEKLOVA, S. KOBZOVA, L. JANDA, Lenka LIŠKOVÁ, Daniel DIABELKO, Tibor BOTKA, Roman PANTŮČEK, Filip RŮŽIČKA and L. VOJTOVA. Phage therapy combined with Gum Karaya injectable hydrogels for treatment of methicillin-resistant Staphylococcus aureus deep wound infection in a porcine model. International Journal of Pharmaceutics. AMSTERDAM: ELSEVIER, 2024, vol. 660, July 2024, p. 1-11. ISSN 0378-5173. Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124348.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Phage therapy combined with Gum Karaya injectable hydrogels for treatment of methicillin-resistant Staphylococcus aureus deep wound infection in a porcine model
Authors VACEK, Lukáš (203 Czech Republic, belonging to the institution), Dominika POLAŠTÍK KLEKNEROVÁ (703 Slovakia, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Dominika MATYSKOVÁ (203 Czech Republic, belonging to the institution), E. CERNA (203 Czech Republic), J. BRTNIKOVA (203 Czech Republic), E. JEKLOVA (203 Czech Republic), S. KOBZOVA (203 Czech Republic), L. JANDA (203 Czech Republic), Lenka LIŠKOVÁ (203 Czech Republic, belonging to the institution), Daniel DIABELKO (703 Slovakia, belonging to the institution), Tibor BOTKA (203 Czech Republic, belonging to the institution), Roman PANTŮČEK (203 Czech Republic, belonging to the institution), Filip RŮŽIČKA (203 Czech Republic, belonging to the institution) and L. VOJTOVA (203 Czech Republic).
Edition International Journal of Pharmaceutics, AMSTERDAM, ELSEVIER, 2024, 0378-5173.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30303 Infectious Diseases
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.800 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.ijpharm.2024.124348
UT WoS 001259200500001
Keywords in English Bacteriophage; Phage therapy; Gum Karaya; Hydrogel film; Injectable hydrogel; Staphylococcus aureus; MRSA
Tags 14110113, 14110229, 14110517
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/7/2024 10:08.
Abstract
Skin and soft tissue infections (SSTIs) represent a significant healthcare challenge, particularly in the context of increasing antibiotic resistance. This study investigates the efficacy of a novel therapeutic approach combining bacteriophage (phage) therapy with a gum Karaya (GK)-based hydrogel delivery system in a porcine model of deep staphylococcal SSTIs. The study exploits the lytic activity and safety of the Staphylococcus phage 812K1/ 420 of the Kayvirus genus, which is active against methicillin-resistant Staphylococcus aureus (MRSA). The GK injectable hydrogels and hydrogel films, developed by our research group, serve as effective, non-toxic, and easyto-apply delivery systems, supporting moist wound healing and re-epithelialization. In the porcine model, the combined treatment showed a synergistic effect, leading to a significant reduction in bacterial load (2.5 log CFU/ gram of tissue) within one week. Local signs of inflammation were significantly reduced by day 8, with clear evidence of re-epithelialization and wound contraction. Importantly, no adverse effects of the GK-based delivery system were observed throughout the study. The results highlight the potential of this innovative therapeutic approach to effectively treat deep staphylococcal SSTIs, providing a promising avenue for further research and clinical application in the field of infections caused by antibiotic-resistant bacteria.
Links
NU20-05-00166, research and development projectName: Nové přístupy k hojení infikovaných ran pomocí hydrogelů z přírodní pryskyřice Gum Karaya modifikovaných inovativními komponenty cílenými na multirezistentní kmeny bakterií (Acronym: NPHIRPHGK)
Investor: Ministry of Health of the CR, Subprogram 1 - standard
PrintDisplayed: 28/7/2024 13:17